The oncology therapy landscape is rapidly evolving, with immune checkpoint inhibitors�reshaping cancer treatment by leveraging the body's own immune system to combat tumors. As the immune checkpoint ...
NEW YORK CITY, NY / ACCESS Newswire / March 16, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds ...
NEW YORK, NY / ACCESS Newswire / March 15, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
Biopharma deal activity climbed in early 2025, reaching $37.38 billion in the first two months, up from $35.66 billion a year ...
DelveInsight's "ROZLYTREK Market Size, Forecast, and Market Insight Report" highlights the details around ROZLYTREK, an inhibitor of the ...
After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...
ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...
In the third instalment of our three-part feature Rob Wilson asks Astrid Smitham and Alexander Turner about their experience ...
FORWARD-53 is an ongoing Phase 2 open-label trial of WVE-N531. Muscle biopsies are taken after 24 and 48 weeks of dosing. The ...
The draft agenda also indicated reviews of the GSK meningococcal vaccine and AstraZeneca flu shot. According to the U.S. Department of Health and Human Services, the public is normally allowed time to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback